Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary : Global HIV/AIDS Immunoassay Diagnostics Market


4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)


5. Market Outlook

5.1. Technological Advancements

5.2. Key Industry Developments

5.3. Epidemiology Analysis

5.4. Number of HIV/AIDS Immunoassay Diagnostics Tests, by Region

5.5. Pricing Analysis


6. Global HIV/AIDS Immunoassay Diagnostics Market Value and Forecast, by Product

6.1. Introduction & Definition

6.2. Global HIV/AIDS Immunoassay Diagnostics Market Value Forecast, by Product, 2017–2027

6.2.1. Analyzers

6.2.2. Kits & Reagents

6.3. Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Product


7. Global HIV/AIDS Immunoassay Diagnostics Market Value and Forecast, by Technology

7.1. Introduction

7.2. Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

7.2.1. ELISA

7.2.2. CLIA

7.2.3. Others

7.3. Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Technology


8. Global HIV/AIDS Immunoassay Diagnostics Market Value and Forecast, by End User

8.1. Introduction

8.2. Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027

8.2.1. Hospitals

8.2.2. Diagnostic Laboratories

8.2.3. Blood Banks

8.2.4. Others

8.3. Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by End User


9. Global HIV/AIDS Immunoassay Diagnostics Market Value and Forecast, by Region

9.1. Introduction

9.2. Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017–2027

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Region


10. North America HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast

10.1. Introduction

10.2. North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

10.2.1. Analyzers

10.2.2. Kits & Reagents

10.3. North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

10.3.1. ELISA

10.3.2. CLIA

10.3.3. Others

10.4. North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027

10.4.1. Hospitals

10.4.2. Diagnostic Laboratories

10.4.3. Blood Banks

10.4.4. Others

10.5. North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2027

10.5.1. U.S.

10.5.2. Canada

10.6. North America HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis

10.6.1. By Product

10.6.2. By Technology

10.6.3. By End User

10.6.4. By Country


11. Europe HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast

11.1. Introduction

11.2. Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

11.2.1. Analyzers

11.2.2. Kits & Reagents

11.3. Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

11.3.1. ELISA

11.3.2. CLIA

11.3.3. Others

11.4. Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027

11.4.1. Hospitals

11.4.2. Diagnostic Laboratories

11.4.3. Blood Banks

11.4.4. Others

11.5. Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

11.5.1. Germany

11.5.2. U.K.

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Russia

11.5.7. Rest of Europe

11.6. Europe HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis

11.6.1. By Product

11.6.2. By Technology

11.6.3. By End User

11.6.4. By Country/Sub-region


12. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast

12.1. Introduction

12.2. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

12.2.1. Analyzers

12.2.2. Kits & Reagents

12.3. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

12.3.1. ELISA

12.3.2. CLIA

12.3.3. Others

12.4. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027

12.4.1. Hospitals

12.4.2. Diagnostic Laboratories

12.4.3. Blood Banks

12.4.4. Others

12.5. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

12.5.1. Japan

12.5.2. China

12.5.3. India

12.5.4. Australia & New Zealand

12.5.5. Rest of Asia Pacific

12.6. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis

12.6.1. By Product

12.6.2. By Technology

12.6.3. By End User

12.6.4. By Country/Sub-region

13. Latin America HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast

13.1. Introduction

13.2. Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

13.2.1. Analyzers

13.2.2. Kits & Reagents

13.3. Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

13.3.1. ELISA

13.3.2. CLIA

13.3.3. Others

13.4. Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027

13.4.1. Hospitals

13.4.2. Diagnostic Laboratories

13.4.3. Blood Banks

13.4.4. Others

13.5. Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Latin America HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis

13.6.1. By Product

13.6.2. By Technology

13.6.3. By End User

13.6.4. By Country/Sub-region

14. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast

14.1. Introduction

14.2. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

14.2.1. Analyzers

14.2.2. Kits & Reagents

14.3. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

14.3.1. ELISA

14.3.2. CLIA

14.3.3. Others

14.4. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027

14.4.1. Hospitals

14.4.2. Diagnostic Laboratories

14.4.3. Blood Banks

14.4.4. Others

14.5. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

14.5.1. GCC Countries

14.5.2. South Africa

14.5.3. Rest of Middle East & Africa

14.6. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis

14.6.1. By Product

14.6.2. By Technology

14.6.3. By End User

14.6.4. By Country/Sub-region

15. Competition Landscape

15.1. Market Player – Competition Matrix (By Tier and Size of companies)

15.2. Global HIV/AIDS Immunoassay Diagnostics Market Share Analysis, by Company (2018)

15.3. Company Profiles

15.3.1. F. Hoffmann-La Roche Ltd.

15.3.1.1. Company Description

15.3.1.2. Business Overview

15.3.1.3. Financial Overview

15.3.1.4. Strategic Overview

15.3.1.5. SWOT Analysis

15.3.2. Bio-Rad Laboratories, Inc.

15.3.2.1. Company Description

15.3.2.2. Business Overview

15.3.2.3. Financial Overview

15.3.2.4. Strategic Overview

15.3.2.5. SWOT Analysis

15.3.3. Siemens Healthineers AG.

15.3.3.1. Company Description

15.3.3.2. Business Overview

15.3.3.3. Financial Overview

15.3.3.4. Strategic Overview

15.3.3.5. SWOT Analysis

15.3.4. DiaSorin S.p.A.

15.3.4.1. Company Description

15.3.4.2. Business Overview

15.3.4.3. Financial Overview

15.3.4.4. Strategic Overview

15.3.4.5. SWOT Analysis

15.3.5. Abbott Laboratories

15.3.5.1. Company Description

15.3.5.2. Business Overview

15.3.5.3. Financial Overview

15.3.5.4. Strategic Overview

15.3.5.5. SWOT Analysis

15.3.6. Ortho Clinical Diagnostics (a part of Carlyle Group)

15.3.6.1. Company Description

15.3.6.2. Business Overview

15.3.6.3. Financial Overview

15.3.6.4. Strategic Overview

15.3.6.5. SWOT Analysis

15.3.7. Shenzhen New Industries Biomedical Engineering Co., Ltd.

15.3.7.1. Company Description

15.3.7.2. Business Overview

15.3.7.3. Financial Overview

15.3.7.4. Strategic Overview

15.3.7.5. SWOT Analysis

15.3.8. bioM?rieux SA

15.3.8.1. Company Description

15.3.8.2. Business Overview

15.3.8.3. Financial Overview

15.3.8.4. Strategic Overview

15.3.8.5. SWOT Analysis

15.3.9. Fujirebio (Miraca Group)

15.3.9.1. Company Description

15.3.9.2. Business Overview

15.3.9.3. Financial Overview

15.3.9.4. Strategic Overview

15.3.9.5. SWOT Analysis



List of Figures



Figure 01: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) and Distribution (%), by Region, 2019 and 2027

Figure 02: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

Figure 03: Global HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Product, 2018

Figure 04: Global HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Technology, 2018

Figure 05: Global HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by End User, 2018

Figure 06: Global HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Region, 2018

Figure 07: HIV/AIDS Immunoassay Diagnostics Market – Mergers, Acquisitions, Collaborations, Partnerships & New Product Launch

Figure 08: Technological Advancements

Figure 09: Global HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Product, 2018 and 2027

Figure 10: Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Product, 2019–2027

Figure 11: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Analyzers, 2017–2027

Figure 12: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Kits & Reagents, 2017–2027

Figure 13: Global HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Technology, 2018 and 2027

Figure 14: Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Technology, 2019–2027

Figure 15: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by ELISA, 2017–2027

Figure 16: Global Ne HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CLIA, 2017–2027

Figure 17: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 18: Global HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by End User, 2018 and 2027

Figure 19: Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by End User, 2019–2027

Figure 20: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027

Figure 21: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2017–2027

Figure 22: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood Banks, 2017–2027

Figure 23: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 24: Global HIV/AIDS Immunoassay Diagnostics Market Value Share Analysis, by Region, 2018 and 2027

Figure 25: Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis, by Region, 2019–2027

Figure 26: North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 27: North America HIV/AIDS Immunoassay Diagnostics Market Value Share Analysis, by Country, 2018 and 2027

Figure 28: North America HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis, by Country, 2019–2027

Figure 29: North America HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Product, 2018 and 2027

Figure 30: North America HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Product, 2019–2027

Figure 31: North America HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Technology, 2018 and 2027

Figure 32: North America HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Technology, 2019–2027

Figure 33: North America HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by End User, 2018 and 2027

Figure 34: North America HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by End User, 2019–2027

Figure 35: Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 36: Europe HIV/AIDS Immunoassay Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 37: Europe HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 38: Europe HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Product, 2018 and 2027

Figure 39: Europe HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Product, 2019–2027

Figure 40: Europe HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Technology, 2018 and 2027

Figure 41: Europe HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Technology, 2019–2027

Figure 42: Europe HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by End User, 2018 and 2027

Figure 43: Europe HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by End User, 2019–2027

Figure 44: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 45: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 46: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 47: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Product, 2018 and 2027

Figure 48: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Product, 2019–2027

Figure 49: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Technology, 2018 and 2027

Figure 50: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Technology, 2019–2027

Figure 51: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by End User, 2018 and 2027

Figure 52: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by End User, 2019–2027

Figure 53: Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 54: Latin America HIV/AIDS Immunoassay Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 55: Latin America HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 56: Latin America HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Product, 2018 and 2027

Figure 57: Latin America HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Product, 2019–2027

Figure 58: Latin America HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Technology, 2018 and 2027

Figure 59: Latin America HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Technology, 2019–2027

Figure 60: Latin America HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by End User, 2018 and 2027

Figure 61: Latin America HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by End User, 2019–2027

Figure 62: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 63: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 64: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 65: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Product, 2018 and 2027

Figure 66: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Product, 2019–2027

Figure 67: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Technology, 2018 and 2027

Figure 68: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Technology, 2019–2027

Figure 69: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by End User, 2018 and 2027

Figure 70: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by End User, 2019–2027

Figure 71: Global HIV/AIDS Immunoassay Diagnostics Market Share Analysis, by Company, 2018


List of Tables


List of Tables

Table 01: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 02: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 03: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027

Table 04: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 05: North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 06: North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 07: North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 08: North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027

Table 09: Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 10: Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 11: Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 12: Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027

Table 13: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 14: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 15: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 16: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027

Table 17: Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 18: Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 19: Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 20: Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027

Table 21: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 22: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 23: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 24: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027